RHB-107 P2/3 COVID-19 Study South Africa Approval

Go back to RHB-107 P2/3 COVID-19 Study South Africa Approval
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.66 +0.03 (4.76%)
Previous Close $0.63    52 Week High $16.54 
Open $0.64    52 Week Low $8.10 
Day High $0.70    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 42,434